CTOs on the Move

OCO BioMedical

www.ocobiomedical.com

 
OCO BioMedical is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Davidson

Davidson is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biomerica

Biomerica is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WOMBA

Today, with literally thousands of sports apps, medical apps, nutritional apps and of course doctors` offices and hospitals offering online access to your medical records the chances of anyone checking all their vitals, nutritional intake etc. is close to nil… Why? Way too much data!! WoMBA takes all your data sources and aggregates it under one platform. Aggregated data allows you to see a full picture of your health and gives you a full profile of your E-DNA. Not only does utilizing WoMBA give you easy access to your collected data but many insurance companies will give you a discount for using services such as WoMBA and last but not list, if not the most important, WoMBA can save your life.

Epione Medical Corporation

Epione Medical Corporation is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

iCAD

With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.